This site is intended for US products only. Other countries »

Keeping it Cool

Controlling core temperature

Reducing the likelihood of esophageal injury during RF cardiac ablations

Proactive Esophageal Cooling

Proactive Esophageal Cooling

The ensoETM® thermal regulating device reduces the likelihood of
esophageal injury during RF cardiac ablation procedures. It is also the
only FDA-cleared device on the market that uses the esophageal
environment for full body temperature control.

Proactive Esophageal Cooling

Mark Metzl, MD, FHRS
Endeavor Health

Learning Center

Reduced Procedure Time and Variability with Active Esophageal Cooling During Radiofrequency Ablation for Atrial Fibrillation

This study utilized advanced informatics techniques to compare procedure duration in patients undergoing radio frequency atrial ablation treated with active esophageal cooling to those treated…

Read More

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management

This study presents a novel method to provide efficient patient temperature control for cooling or warming patients.

Read More

Normothermia Protocols for the Neurologically Impaired Patient

Dr. Joseph Haymore is the Senior Nurse Practitioner on the Neurocritical Care Unit at the University of Maryland and Assistant Professor at the University of Maryland School of Nursing. In this webinar…

Read More

Latest Company Updates

Haemonetics Corporation Completes Acquisition of Attune Medical

Haemonetics Corporation, a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, has completed its acquisition of Attune Medical, the manufacturer of the ensoETM® proactive esophageal cooling device.

Read More

Study Finds Significant Reduction in Esophageal Injury Rate When Using ensoETM™ During Cardiac Radiofrequency Ablation Procedures

The study, “Atrioesophageal Fistula Rates Before and After Adoption of Active Esophageal Cooling During Atrial Fibrillation Ablation”, set out to compare the rate of AEFs before and after the adoption of proactive esophageal cooling.

Read More

Attune Medical’s ensoETM® Granted FDA De Novo Marketing Authorization to Reduce the Likelihood of Ablation-related Esophageal Injury Resulting from Radiofrequency Cardiac Ablation Procedures

The FDA based its decision on pre-clinical studies ….

Read More